WTI Price Forecast: More downside is likely if Oil falls below $67
West Texas Intermediate (WTI), futures on NYMEX, trades 1% higher to near $69.40 during the European trading session on Tuesday. The oil price gains after reports that Iran attacked at least two commercial ships transiting through the Strait of Hormuz, a vital passage to almost one-fifth of global energy supply, renewing fears of supply disruptions.
According to an Axios report, Iran fired at least two missiles at commercial ships transiting through the Hormuz. Two commercial ships were hit and suffered significant damage, but no casualties were reported, Bloomberg reported.
While the impact of the event is expected to be limited, as the United States (US) has not delivered any remark regarding the matter, suggesting that the ceasefire with Iran remains intact.
However, US President Donald Trump threatened to attack Iranian infrastructure on Monday if it doesn’t finalize a deal soon.
In response, Iran’s Foreign Minister Abbas Araghchi has warned, “Negotiations on a final deal will not commence if threats continue. Honour your signature.”
Meanwhile, the announcement of a hike in the overall oil output by the OPEC+ has increased the global supply, a scenario that weighs on oil prices.
WTI technical analysis
Bias: WTI US Oil trades higher at around $69.29 at press time. However, the index maintains a bearish near-term bias as spot prices hold well below the 20-day Exponential Moving Average (EMA) at $74.27.
Momentum: The separation between price and the EMA suggests sellers remain in control, while the Relative Strength Index (RSI) at 31.79 hovers just above oversold territory, hinting that downside momentum is still dominant but approaching levels where selling pressure could begin to moderate.
Resistance: On the topside, the immediate resistance is $70.00, followed by the 20-day EMA near $74.27.
Support: The Oil price might enter a fresh downside leg if it breaks below the July 2 low at $67.09. A downside move below $67.09 would expose the oil price to the February 26 low at $63.58.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

